Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma
Clinical trial NCT00392990 · COMPLETED
Trial details
- NCT number
- NCT00392990
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-06
- Primary completion
- 2011-12-03
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.